Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity

Journal of Medicinal Chemistry
H HattoriAkira Matsuda

Abstract

We previously designed 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil (EUrd) as a potential multifunctional antitumor nucleoside antimetabolite. It showed a potent and broad spectrum of antitumor activity against various human tumor cells in vitro and in vivo. To determine the structure-activity relationship, various nucleobase analogues of EUrd, such as 5-fluorouracil, thymine, cytosine, 5-fluorocytosine, adenine, and guanine derivatives, were synthesized by condensation of 1-O-acetyl-2,3,5-tri-O-benzoyl-3-C-ethynyl-alpha,beta-D-ribo-pentofur anose (6) and the corresponding pertrimethylsilylated nucleobases in the presence of SnCl4 or TMSOTf as a Lewis acid in CH3CN followed by debenzoylation. The in vitro tumor cell growth inhibitory activity of these 3'-C-ethynyl nucleosides against mouse leukemia L1210 and human nasopharyngeal KB cells showed that 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd) and EUrd were the most potent inhibitors in the series, with IC50 values for L1210 cells of 0.016 and 0.13 microM and for KB cells of 0.028 and 0.029 microM, respectively. 5-Fluorocytosine, 5-fluorouracil, and adenine nucleosides showed much lower activity, with IC50 values of 0.4-2.5 microM, while thymine and guanine nuc...Continue Reading

References

Sep 1, 1991·Journal of Medicinal Chemistry·N B MantloC S Sweet
Feb 1, 1991·Journal of Medicinal Chemistry·R FossheimS G Dahl
Jun 1, 1988·Journal of Medicinal Chemistry·K TakenukiK Yamagami
Dec 13, 1974·The Journal of Organic Chemistry·U Niedballa, H Vorbrüggen
Aug 18, 1994·Nature·U Uhlin, H Eklund

❮ Previous
Next ❯

Citations

Aug 1, 2008·Cancer Chemotherapy and Pharmacology·Tomoharu NaitoHye-Sook Kim
Sep 15, 2005·Journal of Cancer Research and Clinical Oncology·Marina PavlakMarko Radacić
Dec 4, 2009·Investigational New Drugs·Irene V BijnsdorpGodefridus J Peters
May 26, 2005·Il Farmaco·Ljubica Glavas-ObrovacBiserka Zinić
Apr 25, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·R KitamuraY Kawaguchi
Feb 1, 2003·Journal of Pharmaceutical and Biomedical Analysis·Kazuaki MatsuokaYasuro Kawaguchi
Mar 27, 2012·Nucleosides, Nucleotides & Nucleic Acids·Jeremy L ClarkJ Christian Mason
Jun 21, 2007·Nucleosides, Nucleotides & Nucleic Acids·Matt A PetersonW Edward Robinson
Dec 7, 2007·Nucleosides, Nucleotides & Nucleic Acids·Hyung Ryong MoonLak Shin Jeong
Dec 11, 2007·Nucleosides, Nucleotides & Nucleic Acids·Ashok K PrasadVirinder S Parmar
Feb 26, 2010·Nucleosides, Nucleotides & Nucleic Acids·Hiroshi Ohrui
Aug 2, 2008·Chemical & Pharmaceutical Bulletin·Satoshi Ichikawa
Oct 2, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Satoshi Ichikawa
Mar 23, 2011·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Hiroshi Ohrui
Feb 18, 2004·Cancer Science·Akira Matsuda, Takuma Sasaki
May 17, 2005·Nucleosides, Nucleotides & Nucleic Acids·Tatsushi YokogawaYusuke Wataya
May 3, 2002·Japanese Journal of Cancer Research : Gann·Yuji ShimamotoMasakazu Fukushima
Mar 21, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Christophe Len, Gérald Enderlin
Mar 27, 2001·Japanese Journal of Cancer Research : Gann·Y ShimamotoM Fukushima
Mar 25, 2006·Organic & Biomolecular Chemistry·Satoshi IchikawaAkira Matsuda
Sep 29, 2019·Nucleosides, Nucleotides & Nucleic Acids·Hironobu YasuiOsamu Inanami
Nov 27, 2001·Nucleosides, Nucleotides & Nucleic Acids·J DauvergneJ F Biellmann
Sep 26, 2012·Acta Crystallographica. Section C, Crystal Structure Communications·Frank SeelaHans Reuter
Jan 1, 1999·Bioscience, Biotechnology, and Biochemistry·R YamaguchiH Ohrui
Jun 13, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Miklós BegeAnikó Borbás
Sep 21, 2001·Nucleosides, Nucleotides & Nucleic Acids·A AzumaM Fukushima

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.